Browse by Series:

Prognosticating BRAF-Mutant mCRC

Insights From: Scott Kopetz, MD, PhD, FACP, The University of Texas MD Anderson Cancer Center; Ryan Corcoran, MD, PhD, Massachusetts General Hospital Cancer Center
Published: Thursday, Jan 31, 2019



Gastrointestinal oncology experts provide insight on the management and prognostic significance of BRAF-mutant metastatic colorectal cancer (mCRC).
SELECTED
LANGUAGE
Slider Left
Slider Right


Gastrointestinal oncology experts provide insight on the management and prognostic significance of BRAF-mutant metastatic colorectal cancer (mCRC).
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
x